Insider trade

Director sold ~$1.27M of BSX shares in the open market

Traded Nov 6, 2025 · Filed Nov 6, 2025

~$1.27M
Reported value · 13K sh @ $98.2839: 24K
Holds after · shares reported: -56.4%
stock since the trade · S&P 500 +14.0%, $99.05 → $43.23 on Oct 1

Why it stands out

A board member of Boston Scientific sold $1.27M of Boston Scientific shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Nov 6, 2025
Reporting period: Not applicable
Filed with the SEC: Nov 6, 2025

Director$1M+Pre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$1,266,978

Shares × reported transaction price

Timing vs results

15 days after results of Oct 22, 2025, 90 days before results of Feb 4, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $99.05 on Nov 6, 2025, 14% above its 52-week low and 8% below its high, little changed over the previous 30 trading days

52-week range $86.88 (Nov 7, 2024) to $108.14 (Sep 8, 2025), 57% of the way up, from 250 adjusted closes. 30 trading days earlier: $98.14 on Sep 25, 2025. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	+2.7%	+0.1%	+2.5%
30 days	-6.2%	+1.9%	-8.1%
90 days	-22.4%	+1.0%	-23.4%
180 days	-44.0%	+9.4%	-53.4%

Past results only. Not a forecast.

Source receipt

Record ID: 0001225208-25-008997
Filed / recorded: Nov 6, 2025, 9:34 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: BOSTON SCIENTIFIC CORP
Issuer CIK: 885725
Ticker: BSX
Reporting person: Ellen M Zane
Relationship: Director
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Nov 6, 2025
Transaction code: S
Shares / units: 12,891
Price per share: $98.2839
Acquired / disposed: Disposed (D)
Shares owned after: 24,134
Ownership form: Direct
Amendment: No

Footnotes from the filing

The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on July 25, 2025.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $97.89 to $98.65, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Around the same time

10mo ago

6,952Shares · @ $27.09

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

10mo ago

6,175Shares · @ $24.55

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

10mo ago

3,177Shares · @ $22.71

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record